Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-006406

ANAPTYSBIO, INC · ANAB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
James N Topper
Director · 10% Owner
Period of report
Jan 31, 2017
Accepted (ET)
Jan 31, 2017 · 4:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001370053

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jan 31, 2017C2,228,377$0.00A2,228,377Isee footnote
Common StockF1,F3Jan 31, 2017C733,740$0.00A733,740Isee footnote
Common StockF1,F4Jan 31, 2017C209,095$0.00A209,095Isee footnote
Common StockF3Jan 31, 2017P311,291$15.00A1,045,031Isee footnote
Common StockF4Jan 31, 2017P88,709$15.00A297,804Isee footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series B Preferred StockF2,F1$0.00Jan 31, 2017C1,428,571D——Common Stock1,428,5710I
Series C Preferred StockF2,F1$0.00Jan 31, 2017C604,055D——Common Stock604,0550I
Series C-1 Preferred StockF2,F1$0.00Jan 31, 2017C195,751D——Common Stock195,7510I
Series D Preferred StockF3,F1$0.00Jan 31, 2017C733,740D——Common Stock733,7400I
Series D Preferred StockF4,F1$0.00Jan 31, 2017C209,095D——Common Stock209,0950I

Explanation of responses